Alkem Laboratories Limited
BNP Paribas bought 48,090 shares of Alkem Laboratories for ₹25.01 Cr at ₹5200.00 apiece in a block deal. This was part of a larger transaction where promoter family entities divested shares to various institutional investors.
A pharmaceutical company engaged in the development, manufacture, and sale of drugs and nutraceutical products across global markets. The company operates research-driven facilities to serve both domestic and international customers with a focus on therapeutic innovation. Its distinctive approach combines pharmaceutical manufacturing expertise with nutraceutical offerings to address diverse healthcare needs and patient populations worldwide.
French global bank with around EUR 2.6 trillion in assets. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.